title: [ETHICS, MORALS AND SOCIETY IN PERSONALIZED MEDICINE].
abstract: Following the completion of the human genome project, genomic medicine including personalized medicine, widely based on pharmacogenetics and pharmacogenomics, is rapidly developing. This breakthrough should benefit humankind thanks to tailoring the most appropriate prevention, interventions and therapies to each individual, minimizing adverse side effects, based on inter-personal genetic variety and polymorphism. Yet wide spectrum ethical, legal and social issues carry significant implications regarding individuals, families, society and public health. The main issues concern genomic information and autonomy, justice and equity, resources allocation and solidarity, challenging the traditional role of medicine and dealing with unlimited boundaries of knowledge. Those issues are not new nor exceptional to genomic medicine, yet their wide unlimited scope and implications on many aspects of life renders them crucial. These aspects will be discussed in light of Beauchamp and Childress' four principles: non-maleficence, beneficence, autonomy and justice, and main moral philosophies, Kant's autonomy, Utilitarianism which promotes the common good, and Rawls' Theory of Justice.
authors.forename: Anath
authors.initials: A
authors.lastname: Flugelman
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D004992:Ethics, Medical; D023281:Genomics / Q000941:ethics; D006801:Humans; D009014:Morals; D010597:Pharmacogenetics / Q000941:ethics*; D057285:Precision Medicine / Q000941:ethics*; D011634:Public Health / Q000941:ethics; D012935:Social Justice